Dysplasia Clinical Trials

5 recruiting

Dysplasia Trials at a Glance

153 actively recruiting trials for dysplasia are listed on ClinicalTrialsFinder across 6 cities in 40 countries. The largest study group is Not Applicable with 49 trials, with the heaviest enrollment activity in Chicago, Rochester, and New York. Lead sponsors running dysplasia studies include Mayo Clinic, Masonic Cancer Center, University of Minnesota, and Children's Hospital of Philadelphia.

Browse dysplasia trials by phase

Treatments under study

About Dysplasia Clinical Trials

Looking for clinical trials for Dysplasia? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Dysplasia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Dysplasia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 153 trials

Recruiting
Phase 1

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Leukemia, Lymphocytic, AcuteBlood CancerMyeloid Leukemia, Acute+8 more
National Cancer Institute (NCI)86 enrolled1 locationNCT06904066
Recruiting
Phase 2

Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Acute Myeloid LeukemiaAcute Myeloid Leukemia Post Cytotoxic TherapyAcute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm+1 more
National Cancer Institute (NCI)335 enrolled220 locationsNCT05554406
Recruiting
Phase 2

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid LeukemiaMyelodysplastic SyndromeAcute Myeloid Leukemia Post Cytotoxic Therapy+2 more
National Cancer Institute (NCI)2,000 enrolled346 locationsNCT05564390
Recruiting
Phase 2

Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and Below

Bronchopulmonary Dysplasia
International Peace Maternity and Child Health Hospital29 enrolled1 locationNCT07561125
Recruiting

Mayo AVC Registry and Biobank

CardiomyopathiesCardiovascular DiseasesHeart Diseases+5 more
Mayo Clinic1,000 enrolled2 locationsNCT03049254
Recruiting

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Ovarian CancerCervical CancerEndometrial Cancer+3 more
Mayo Clinic3,110 enrolled24 locationsNCT05051722
Recruiting

Genetic and Functional Analysis of Craniometaphyseal Dysplasia (CMD)

Craniometaphyseal Dysplasia
UConn Health600 enrolled1 locationNCT01630460
Recruiting

Survey on Physical Activity and Qualify of Life in Fibromuscular Dysplasia

Fibromuscular DysplasiaFibromuscular Dysplasia of ArteriesSpontaneous Coronary Artery Dissection
Vanderbilt University Medical Center2,000 enrolled1 locationNCT07529691
Recruiting
Phase 2Phase 3

Can PLIA Reduce Early Post-operative Pain After PAO Surgery?

Hip Dysplasia
Michael C Willey120 enrolled1 locationNCT06519955
Recruiting
Early Phase 1

Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDH

Developmental Dysplasia of the Hip
Children's Hospital of Philadelphia125 enrolled1 locationNCT03107520
Recruiting
Not Applicable

EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))

Rheumatoid ArthritisOsteoarthritisTraumatic Arthritis+3 more
DePuy Orthopaedics118 enrolled5 locationsNCT06631638
Recruiting
Phase 2

Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas

Esophageal AdenocarcinomaBarrett's Esophagus Without DysplasiaBarrett Oesophagitis With Dysplasia
University Medical Center Groningen25 enrolled1 locationNCT05745857
Recruiting
Not Applicable

A Study Of Exercise In Patients With Spontaneous Coronary Artery Dissection And Fibromuscular Dysplasia

Fibromuscular DysplasiaSpontaneous Coronary Artery Dissection
Mayo Clinic28 enrolled1 locationNCT07526766
Recruiting

The Fibrodysplasia Ossificans Progressiva (FOP) Registry

Fibrodysplasia Ossificans Progressiva (FOP)
The International FOP Association800 enrolled1 locationNCT02745158
Recruiting
Not Applicable

Using Artificial Intelligence to Screen for Hip Dysplasia

Developmental Dysplasia of Hip
Murdoch Childrens Research Institute240 enrolled1 locationNCT06647225
Recruiting
Phase 2

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+21 more
Masonic Cancer Center, University of Minnesota70 enrolled1 locationNCT05735717
Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Heart FailurePainInsomnia+22 more
Duke University5,000 enrolled51 locationsNCT04278404
Recruiting
Phase 2

IVIG Trial for the Treatment of Bronchopulmonary Dysplasia

Bronchopulmonary Dysplasia
International Peace Maternity and Child Health Hospital20 enrolled1 locationNCT06925360
Recruiting
Phase 1

Inhaled Ciclesonide Study in Preterm Infants

Bronchopulmonary Dysplasia
Venkatesh Sampath30 enrolled1 locationNCT06589245
Recruiting
Not Applicable

Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants

Pulmonary HypertensionBronchopulmonary Dysplasia
University of Alabama at Birmingham39 enrolled2 locationsNCT06373289